cardiovascular-agents and Lymphoma--Large-B-Cell--Diffuse

cardiovascular-agents has been researched along with Lymphoma--Large-B-Cell--Diffuse* in 1 studies

Other Studies

1 other study(ies) available for cardiovascular-agents and Lymphoma--Large-B-Cell--Diffuse

Article	Year
Cutaneous and subcutaneous necrosis following dexrazoxane-CHOP therapy. The Annals of pharmacotherapy, 1999, Volume: 33, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cardiovascular Agents; Cyclophosphamide; Doxorubicin; Fatal Outcome; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Necrosis; Prednisone; Razoxane; Skin; Vincristine	1999

Article

Year

Cutaneous and subcutaneous necrosis following dexrazoxane-CHOP therapy.

The Annals of pharmacotherapy, 1999, Volume: 33, Issue:2

Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cardiovascular Agents; Cyclophosphamide; Doxorubicin; Fatal Outcome; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Necrosis; Prednisone; Razoxane; Skin; Vincristine

1999